GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (FRA:65G) » Definitions » Price-to-Funds-From-Operations

NextCell Pharma AB (FRA:65G) Price-to-Funds-From-Operations : (As of Apr. 26, 2025)


View and export this data going back to 2020. Start your Free Trial

What is NextCell Pharma AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


NextCell Pharma AB Business Description

Industry
Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.